Is 3-(Butylamino)-4-phenoxy-5-sulfamoylbenzoic acid Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use 3-(Butylamino)-4-phenoxy-5-sulfamoylbenzoic acid? Is 3-(Butylamino)-4-phenoxy-5-sulfamoylbenzoic acid safe for nursing mother and child? Does 3-(Butylamino)-4-phenoxy-5-sulfamoylbenzoic acid extracts into breast milk? Does 3-(Butylamino)-4-phenoxy-5-sulfamoylbenzoic acid has any long term or short term side effects on infants? Can 3-(Butylamino)-4-phenoxy-5-sulfamoylbenzoic acid influence milk supply or can 3-(Butylamino)-4-phenoxy-5-sulfamoylbenzoic acid decrease milk supply in lactating mothers?
3-(Butylamino)-4-phenoxy-5-sulfamoylbenzoic acid lactation summary
- DrLact safety Score for 3-(Butylamino)-4-phenoxy-5-sulfamoylbenzoic acid is 3 out of 8 which is considered Low Risk as per our analyses.
- A safety Score of 3 indicates that usage of 3-(Butylamino)-4-phenoxy-5-sulfamoylbenzoic acid may cause some minor side effects in breastfed baby.
- Our study of different scientific research indicates that 3-(Butylamino)-4-phenoxy-5-sulfamoylbenzoic acid may cause moderate to no side effects in lactating mother.
- Most of scientific studies and research papers declaring usage of 3-(Butylamino)-4-phenoxy-5-sulfamoylbenzoic acid low risk in breastfeeding are based on normal dosage and may not hold true for higher dosage.
- While using 3-(Butylamino)-4-phenoxy-5-sulfamoylbenzoic acid We suggest monitoring child for possible reactions. It is also important to understand that side effects vary largely based on age of breastfed child and time of medication in addition to dosage.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
Answer by Dr. Ru: About 3-(Butylamino)-4-phenoxy-5-sulfamoylbenzoic acid usage in lactation
Loop diuretic. Long-term treatment with diuretic drugs (particularly those Thiazides with long lasting effect and loop-acting drugs) may inhibit lactation. Use a lower dose as possible, especially during the first postnatal month.
Answer by DrLact: About 3-(Butylamino)-4-phenoxy-5-sulfamoylbenzoic acid usage in lactation
It is unknown if 3-(Butylamino)-4-phenoxy-5-sulfamoylbenzoic acid is excreted into breastmilk. It should be avoided while breastfeeding a newborn because it may decrease milk flow or completely suppress lactation. Low doses in mothers whose lactation is well established are unlikely to suppress lactation. In general, alternate drugs are preferred.
3-(Butylamino)-4-phenoxy-5-sulfamoylbenzoic acid Possible Effects in Breastfeeding
Relevant published information on 3-(Butylamino)-4-phenoxy-5-sulfamoylbenzoic acid was not found as of the revision date. Intense diuresis, fluid restriction and breast binding have been used to suppress lactation immediately postpartum.[1][2][3] The added contribution of the diuretic to the other measures, which are effective in suppressing lactation, has not been studied. No data exist on the effects of loop diuretics on established, ongoing lactation.
Alternate Drugs
Eprosartan(Low Risk)
Benazepril(Safe)
Carvedilol(Low Risk)
Furosemide(Low Risk)
Doxazosin(Safe)
Nitrendipine(Safe)
Amlodipine(Low Risk)
Bisoprolol(Low Risk)
Fosinopril(Low Risk)
Nisoldipine(Low Risk)
Felodipine(Low Risk)
Guanfacine(Low Risk)
Nimodipine(Safe)
Atenolol(Unsafe)
Nifedipine(Safe)
Bosentan(Low Risk)
Nicardipine(Safe)
Acebutolol(Unsafe)
Enalapril(Safe)
Timolol(Safe)
Minoxidil(Safe)
Nebivolol(Unsafe)
Verapamil(Safe)
Diltiazem(Safe)
Sotalol(Low Risk)
Propranolol(Safe)
Methyldopa(Safe)
Valsartan(Low Risk)
Trandolapril(Dangerous)
Chlorthalidone(Dangerous)
Terazosin(Unsafe)
Chlorothiazide(Safe)
Lisinopril(Low Risk)
Telmisartan(Unsafe)
Torsemide(Low Risk)
Captopril(Safe)
Nadolol(Unsafe)
Isradipine(Low Risk)
Prazosin(Unsafe)
Spironolactone(Safe)
Metoprolol(Safe)
Indapamide(Low Risk)
Reserpine(Unsafe)
Bumetanide(Low Risk)
Losartan(Low Risk)
Ramipril(Low Risk)
Levobunolol(Low Risk)
Hydrochlorothiazide(Safe)
Irbesartan(Unsafe)
Bendroflumethiazide(Unsafe)
Labetalol(Safe)
Hydralazine(Safe)
Furosemide(Low Risk)
Torsemide(Low Risk)
Bumetanide(Low Risk)